Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure

Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatme...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Transplant international 2022-03, Vol.35, p.10108-10108
Hauptverfasser: Schulz, Martin S, Gu, Wenyi, Schnitzbauer, Andreas A, Trebicka, Jonel
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 10108
container_issue
container_start_page 10108
container_title Transplant international
container_volume 35
creator Schulz, Martin S
Gu, Wenyi
Schnitzbauer, Andreas A
Trebicka, Jonel
description Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.
doi_str_mv 10.3389/ti.2022.10108
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099355</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2665109655</sourcerecordid><originalsourceid>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</originalsourceid><addsrcrecordid>eNpVkc1LAzEQxYMoVqtHr7JHL1vz0Ww2F6EsVoVCD9ZzyCZZG9kmNckW_O_dflgqDMzA_HgzvAfAHYIjQkr-mOwIQ4xHCCJYnoErNCY4x5ix85N5AK5j_IIQ4pLCSzAglDI8LtgVeJ_ZjQnZIkgX1610SSbrXSZjJrPKB2dCTN6ZHjAyrYxLWeNDNlFdMvnc5dUyeGdVtleZStt2wdyAi0a20dwe-hB8TJ8X1Ws-m7-8VZNZrghiKVcMUYJRwSimFEuEMUSEM250gyjETc01xX1xxFmtYQE1LHVBNNelKmuqyBA87XXXXb0yWvXfBdmKdbArGX6El1b83zi7FJ9-IzjkvLegF3g4CAT_3ZmYxMpGZdreB-O7KHBRUAR5sUPzPaqCjzGY5ngGQbENQiQrtkGIXRA9f3_625H-c578Aj9-g9s</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2665109655</pqid></control><display><type>article</type><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><source>DOAJ Directory of Open Access Journals</source><source>PubMed Central Open Access</source><source>EZB-FREE-00999 freely available EZB journals</source><source>PubMed Central</source><creator>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</creator><creatorcontrib>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</creatorcontrib><description>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</description><identifier>ISSN: 1432-2277</identifier><identifier>ISSN: 0934-0874</identifier><identifier>EISSN: 1432-2277</identifier><identifier>DOI: 10.3389/ti.2022.10108</identifier><identifier>PMID: 35572467</identifier><language>eng</language><publisher>Switzerland: Frontiers Media S.A</publisher><subject>Health Archive</subject><ispartof>Transplant international, 2022-03, Vol.35, p.10108-10108</ispartof><rights>Copyright © 2022 Schulz, Gu, Schnitzbauer and Trebicka.</rights><rights>Copyright © 2022 Schulz, Gu, Schnitzbauer and Trebicka. 2022 Schulz, Gu, Schnitzbauer and Trebicka</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</citedby><cites>FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC9099355/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,864,885,27924,27925,53791,53793</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/35572467$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schulz, Martin S</creatorcontrib><creatorcontrib>Gu, Wenyi</creatorcontrib><creatorcontrib>Schnitzbauer, Andreas A</creatorcontrib><creatorcontrib>Trebicka, Jonel</creatorcontrib><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><title>Transplant international</title><addtitle>Transpl Int</addtitle><description>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</description><subject>Health Archive</subject><issn>1432-2277</issn><issn>0934-0874</issn><issn>1432-2277</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><recordid>eNpVkc1LAzEQxYMoVqtHr7JHL1vz0Ww2F6EsVoVCD9ZzyCZZG9kmNckW_O_dflgqDMzA_HgzvAfAHYIjQkr-mOwIQ4xHCCJYnoErNCY4x5ix85N5AK5j_IIQ4pLCSzAglDI8LtgVeJ_ZjQnZIkgX1610SSbrXSZjJrPKB2dCTN6ZHjAyrYxLWeNDNlFdMvnc5dUyeGdVtleZStt2wdyAi0a20dwe-hB8TJ8X1Ws-m7-8VZNZrghiKVcMUYJRwSimFEuEMUSEM250gyjETc01xX1xxFmtYQE1LHVBNNelKmuqyBA87XXXXb0yWvXfBdmKdbArGX6El1b83zi7FJ9-IzjkvLegF3g4CAT_3ZmYxMpGZdreB-O7KHBRUAR5sUPzPaqCjzGY5ngGQbENQiQrtkGIXRA9f3_625H-c578Aj9-g9s</recordid><startdate>20220317</startdate><enddate>20220317</enddate><creator>Schulz, Martin S</creator><creator>Gu, Wenyi</creator><creator>Schnitzbauer, Andreas A</creator><creator>Trebicka, Jonel</creator><general>Frontiers Media S.A</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20220317</creationdate><title>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</title><author>Schulz, Martin S ; Gu, Wenyi ; Schnitzbauer, Andreas A ; Trebicka, Jonel</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c317t-c7153216752552a122013979edf1502fb9d52d529197bd060d08d63d9d8c8b5c3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Health Archive</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schulz, Martin S</creatorcontrib><creatorcontrib>Gu, Wenyi</creatorcontrib><creatorcontrib>Schnitzbauer, Andreas A</creatorcontrib><creatorcontrib>Trebicka, Jonel</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Transplant international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schulz, Martin S</au><au>Gu, Wenyi</au><au>Schnitzbauer, Andreas A</au><au>Trebicka, Jonel</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure</atitle><jtitle>Transplant international</jtitle><addtitle>Transpl Int</addtitle><date>2022-03-17</date><risdate>2022</risdate><volume>35</volume><spage>10108</spage><epage>10108</epage><pages>10108-10108</pages><issn>1432-2277</issn><issn>0934-0874</issn><eissn>1432-2277</eissn><abstract>Acute-on-chronic liver failure (ACLF) is a distinct clinical syndrome, characterized by acute decompensation (AD) of liver cirrhosis, severe systemic inflammation, intra- and extrahepatic organ failures, and a high short-term mortality. Liver transplantation (LT) is a potentially life-saving treatment for patients with decompensated liver cirrhosis and, due to the high mortality rates, particularly for ACLF patients. In the last decade, a plethora of studies has produced compelling evidence in favor of LT in ACLF, demonstrating high post-LT survival rates and excessive waitlist mortality. The importance of LT in these patients is underscored by the fact that no specific therapy for ACLF is available yet, rendering expeditious life-saving LT to be the only feasible treatment option for some ACLF patients. This review aims to provide an overview on pathophysiology, clinical trajectory, and clinical management of ACLF and to delineate the current literature regarding perspectives and limitations of LT as a life-saving treatment option for ACLF patients.</abstract><cop>Switzerland</cop><pub>Frontiers Media S.A</pub><pmid>35572467</pmid><doi>10.3389/ti.2022.10108</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1432-2277
ispartof Transplant international, 2022-03, Vol.35, p.10108-10108
issn 1432-2277
0934-0874
1432-2277
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9099355
source DOAJ Directory of Open Access Journals; PubMed Central Open Access; EZB-FREE-00999 freely available EZB journals; PubMed Central
subjects Health Archive
title Liver Transplantation as a Cornerstone Treatment for Acute-On-Chronic Liver Failure
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T16%3A52%3A42IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Liver%20Transplantation%20as%20a%20Cornerstone%20Treatment%20for%20Acute-On-Chronic%20Liver%20Failure&rft.jtitle=Transplant%20international&rft.au=Schulz,%20Martin%20S&rft.date=2022-03-17&rft.volume=35&rft.spage=10108&rft.epage=10108&rft.pages=10108-10108&rft.issn=1432-2277&rft.eissn=1432-2277&rft_id=info:doi/10.3389/ti.2022.10108&rft_dat=%3Cproquest_pubme%3E2665109655%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2665109655&rft_id=info:pmid/35572467&rfr_iscdi=true